The MiR-17-92 Cluster As a Potential Biomarker for the Early Diagnosis of Gastric Cancer: Evidence and Literature Review

Overview

Journal Oncotarget

Specialty Oncology

Date 2017 Feb 9

PMID 28178677

Citations 21

Authors

Hong Li

Qiong Wu

Ting Li

Changhao Liu

Lin Xue

Jie Ding

Yongquan Shi

Daiming Fan

Affiliations

Soon will be listed here.

Abstract

Purpose: Intestinal metaplasia is considered to be a pre-cancerous lesion of gastric cancer. The miR-17-92 cluster was previously reported to have clinical value in the prediction of cancer development. This study aimed to test the diagnostic value of miR-17-92 in gastric cancer and the intestinal metaplasia patients compared with the normal ones.

Results: The results showed that miR-17-92 members were over-expressed in the serum of both gastric cancer and intestinal metaplasia patients, compared with healthy controls. Serum miR-17-92 members could also distinguish patients with gastric cancer and intestinal metaplasia from healthy controls.

Materials And Methods: Serum miR-17-92 expression levels were detected using quantitative real-time PCR in 75 patients with gastric cancer, 104 patients with intestinal metaplasia and 38 healthy controls. The Receiver operating characteristic (ROC) curves and the area under the ROC curve (AUC) were then analyzed to test the efficacy of the miR-17-92 members in distinguishing gastric cancer, intestinal metaplasia and healthy controls.

Conclusions: In conclusion, the miR-17-92 cluster might be useful as a potential serum biomarker for the early detection of gastric cancer.

Citing Articles

Gastric Intestinal Metaplasia: Challenges and the Opportunity for Precision Prevention.

Tjandra D, Busuttil R, Boussioutas A Cancers (Basel). 2023; 15(15).

PMID: 37568729 PMC: 10417197. DOI: 10.3390/cancers15153913.

A Panel of Circulating microRNAs as a Potential Biomarker for the Early Detection of Gastric Cancer.

Saliminejad K, Mahmoodzadeh H, Soleymani Fard S, Yaghmaie M, Khorshid H, Mousavi S Avicenna J Med Biotechnol. 2022; 14(4):278-286.

PMID: 36504565 PMC: 9706247.

Cancer Stem Cells in Tumor Microenvironment of Adenocarcinoma of the Stomach, Colon, and Rectum.

Islas J, Quiroz-Reyes A, Delgado-Gonzalez P, Franco-Villarreal H, Delgado-Gallegos J, Garza-Trevino E Cancers (Basel). 2022; 14(16).

PMID: 36010940 PMC: 9405851. DOI: 10.3390/cancers14163948.

MicroRNA-20a-5p Downregulation by Atorvastatin: A Potential Mechanism Involved in Lipid-Lowering Therapy.

Saavedra K, Leal K, Saavedra N, Prado Y, Paez I, Ubilla C Int J Mol Sci. 2022; 23(9).

PMID: 35563413 PMC: 9104095. DOI: 10.3390/ijms23095022.

Downregulated miR-18a and miR-92a synergistically suppress non-small cell lung cancer via targeting .

Zhang X, Wang X, Chai B, Wu Z, Liu X, Zou H Bioengineered. 2022; 13(4):11281-11295.

PMID: 35484993 PMC: 9208480. DOI: 10.1080/21655979.2022.2066755.

References

Du M, Liu S, Gu D, Wang Q, Zhu L, Kang M . Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients. Carcinogenesis. 2014; 35(12):2723-30. DOI: 10.1093/carcin/bgu189. View

Luzna P, Gregar J, Uberall I, Radova L, Prochazka V, Ehrmann Jr J . Changes of microRNAs-192, 196a and 203 correlate with Barrett's esophagus diagnosis and its progression compared to normal healthy individuals. Diagn Pathol. 2011; 6:114. PMC: 3268741. DOI: 10.1186/1746-1596-6-114. View

Shan S, Fang L, Shatseva T, Rutnam Z, Yang X, Du W . Mature miR-17-5p and passenger miR-17-3p induce hepatocellular carcinoma by targeting PTEN, GalNT7 and vimentin in different signal pathways. J Cell Sci. 2013; 126(Pt 6):1517-30. DOI: 10.1242/jcs.122895. View

Hirajima S, Komatsu S, Ichikawa D, Takeshita H, Konishi H, Shiozaki A . Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer. 2013; 108(9):1822-9. PMC: 3658511. DOI: 10.1038/bjc.2013.148. View

Rotkrua P, Akiyama Y, Hashimoto Y, Otsubo T, Yuasa Y . MiR-9 downregulates CDX2 expression in gastric cancer cells. Int J Cancer. 2011; 129(11):2611-20. DOI: 10.1002/ijc.25923. View

Wu Q, Luo G, Yang Z, Zhu F, An Y, Shi Y . miR-17-5p promotes proliferation by targeting SOCS6 in gastric cancer cells. FEBS Lett. 2014; 588(12):2055-62. DOI: 10.1016/j.febslet.2014.04.036. View

Wang M, Gu H, Wang S, Qian H, Zhu W, Zhang L . Circulating miR-17-5p and miR-20a: molecular markers for gastric cancer. Mol Med Rep. 2012; 5(6):1514-20. DOI: 10.3892/mmr.2012.828. View

Komatsu S, Ichikawa D, Takeshita H, Morimura R, Hirajima S, Tsujiura M . Circulating miR-18a: a sensitive cancer screening biomarker in human cancer. In Vivo. 2014; 28(3):293-7. View

Guo J, Miao Y, Xiao B, Huan R, Jiang Z, Meng D . Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol. 2009; 24(4):652-7. DOI: 10.1111/j.1440-1746.2008.05666.x. View

10.

Wu Q, Yang Z, An Y, Hu H, Yin J, Zhang P . MiR-19a/b modulate the metastasis of gastric cancer cells by targeting the tumour suppressor MXD1. Cell Death Dis. 2014; 5:e1144. PMC: 3973221. DOI: 10.1038/cddis.2014.110. View

11.

Li T, Lu Y, Zhao X, Guo H, Liu C, Li H . MicroRNA-296-5p increases proliferation in gastric cancer through repression of Caudal-related homeobox 1. Oncogene. 2013; 33(6):783-93. DOI: 10.1038/onc.2012.637. View

12.

Zhi F, Shao N, Wang R, Deng D, Xue L, Wang Q . Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma. Neuro Oncol. 2014; 17(3):383-91. PMC: 4483096. DOI: 10.1093/neuonc/nou169. View

13.

Morimura R, Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, Nagata H . Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer. Br J Cancer. 2011; 105(11):1733-40. PMC: 3242609. DOI: 10.1038/bjc.2011.453. View

14.

Conev N, Donev I, Konsoulova-Kirova A, Chervenkov T, Kashlov J, Ivanov K . Serum expression levels of miR-17, miR-21, and miR-92 as potential biomarkers for recurrence after adjuvant chemotherapy in colon cancer patients. Biosci Trends. 2016; 9(6):393-401. DOI: 10.5582/bst.2015.01170. View

15.

Volinia S, Calin G, Liu C, Ambs S, Cimmino A, Petrocca F . A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006; 103(7):2257-61. PMC: 1413718. DOI: 10.1073/pnas.0510565103. View

16.

Li X, Yang H, Tian Q, Liu Y, Weng Y . Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma. Neoplasma. 2014; 61(4):453-60. DOI: 10.4149/neo_2014_056. View

17.

Wu Q, Yang Z, Wang F, Hu S, Yang L, Shi Y . MiR-19b/20a/92a regulates the self-renewal and proliferation of gastric cancer stem cells. J Cell Sci. 2013; 126(Pt 18):4220-9. DOI: 10.1242/jcs.127944. View

18.

Watanabe H . Intestinal metaplasia -the effect of Acid on the gastric mucosa and gastric carcinogenesis-. J Toxicol Pathol. 2012; 23(3):115-23. PMC: 3234614. DOI: 10.1293/tox.23.115. View

19.

Lin H, Castillo L, Mahon K, Chiam K, Lee B, Nguyen Q . Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer. Br J Cancer. 2014; 110(10):2462-71. PMC: 4021524. DOI: 10.1038/bjc.2014.181. View

20.

Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X . Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer. 2009; 127(1):118-26. DOI: 10.1002/ijc.25007. View